Nexsen Limited (ASX:NXN)
Australia · Delayed Price · Currency is AUD 0.1300
-0.0100 (-7.14%)
Oct 21, 2026, 2:26 PM AEDT
Nexsen Market Cap
Nexsen has a market cap or net worth of 26.03 million as of October 21, 2026. It is the 37,975th most valuable company in the world and the 1,018th biggest in Australia. Its market cap has decreased by 52.73% in one year.
Market Cap
26.03M
Enterprise Value
21.55M
Revenue
n/a
Global Rank
Country Rank
#1,018 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since October 14, 2025, Nexsen's market cap has decreased from 56.05M to 26.03M, a decrease of -53.57%. That is a compound annual growth rate of -52.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 26.03M | -18.75% |
| Dec 31, 2025 | 32.03M | -42.86% |
| Oct 14, 2025 | 56.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amplia Therapeutics | 41.06M |
| Immutep | 33.90M |
| Botanix Pharmaceuticals | 32.84M |
| Neurotech International | 29.09M |
| NeuroScientific Biopharmaceuticals | 22.60M |
| Algorae Pharmaceuticals | 20.28M |
| Proteomics International Laboratories | 19.02M |
| Imugene | 17.63M |